Inflammation, Stress, and Comorbidity in Psychiatry: Mechanisms and Therapeutic Implications

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuropsychiatry".

Deadline for manuscript submissions: closed (20 March 2026) | Viewed by 828

Editor


E-Mail Website
Guest Editor
Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, MC 0603, La Jolla, CA 92093-0603, USA
Interests: early symptoms of psychosis; schizophrenia; bipolar disorder with psychotic features

Special Issue Information

Dear Colleagues,

Nowadays, mental and physical health can no longer be regarded as distinct; rather, they belong to an intertwined network comprising the nervous, endocrine, immune, and gastrointestinal systems. Recent advances in neuroscience, psychoimmunology, and medicine have highlighted the pivotal role of inflammation and chronic stress in the pathophysiology of major psychiatric disorders, including depression, schizophrenia, bipolar disorder, and PTSD. These conditions frequently co-occur with systemic illnesses—such as cardiovascular disease, metabolic syndrome, and autoimmune disorders—suggesting shared biological risk mechanisms.

In this Special Issue of Brain Sciences, we welcome original research, reviews, and perspectives that explore the mechanistic links, neurobiological pathways, and therapeutic implications of inflammation and stress in psychiatric illnesses and their common comorbidities with the emphasis of shared biological mechanisms.

Topics of interest include (but are not limited to) the following:

  • Neuroinflammatory processes in psychiatric disorders (e.g., cytokine signaling, microglial activation);
  • HPA axis dysregulation and its effects on brain function and behavior;
  • The impact of early-life adversity on neuroimmune development—biological risk vs resilience mechanisms;
  • Comorbidity models linking psychiatric and systemic illnesses (e.g., schizophrenia and cardiovascular risk);
  • Neuroimaging and electrophysiological correlates of stress and inflammation;
  • Anti-inflammatory and stress-modulating treatments—pharmacological and behavioral;
  • Personalized and precision medicine approaches in neuropsychiatry;
  • Translational models bridging animal studies and human clinical research.

Dr. Heline Mirzakhanian
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immune biomarkers in psychiatry
  • neuroinflammation
  • precision neuropsychiatry
  • risk mechanisms
  • comorbidity models
  • HPA axis dysregulation
  • anti-inflammatory treatments
  • psychiatric and physical comorbidity
  • cytokine signaling
  • microglial activation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 1950 KB  
Article
Integrated Inflammatory and Gut Microbial Signatures in Major Depressive Disorder: A Case–Control Study
by Nour Dabboussi, Espérance Debs, Marc Bouji, Raymond Kassab, Rami Bou Khalil, Nassim Fares and Rayane Rafei
Brain Sci. 2026, 16(7), 681; https://doi.org/10.3390/brainsci16070681 - 28 Jun 2026
Viewed by 503
Abstract
Background/Objectives: Major depressive disorder (MDD) is increasingly recognized as involving inflammation and the microbiota–gut–brain axis. Few studies have simultaneously assessed systemic inflammatory markers and gut microbiota composition within the same cohort while accounting for metabolic confounders. Moreover, data from Middle Eastern and North [...] Read more.
Background/Objectives: Major depressive disorder (MDD) is increasingly recognized as involving inflammation and the microbiota–gut–brain axis. Few studies have simultaneously assessed systemic inflammatory markers and gut microbiota composition within the same cohort while accounting for metabolic confounders. Moreover, data from Middle Eastern and North African (MENA) populations remain limited, restricting our understanding of how diet may influence neuroimmune–microbiome interactions in depression. This study aimed to investigate associations between MDD, systemic inflammatory markers, and gut microbiota composition in Lebanese adults. To our knowledge, this is the first study of its kind in Lebanon, as well as in the MENA region. Methods: In this cross-sectional case–control study, we examined circulating inflammatory markers and gut microbial profiles in 46 adults with DSM-5-confirmed MDD and 25 healthy controls. Plasma C-reactive protein (CRP) and interleukin-6 (IL-6) were measured, and the gut microbiota composition was characterized using 16S rRNA gene sequencing. Multivariable models were adjusted for age, sex, body mass index (BMI), Mediterranean diet adherence, and fluoxetine exposure. Results: Depression status was not independently associated with CRP or IL-6 after adjustment, whereas BMI emerged as a significant determinant of systemic inflammation. At the genus level, MDD was associated with the enrichment of Dorea, Lachnoclostridium, Collinsella, Bilophila, and Klebsiella and the depletion of Christensenella, Mitsuokella, and Victivallis, independent of inflammatory biomarkers. Alpha diversity did not differ between groups, while beta diversity showed modest metric-dependent differences, primarily driven by presence/absence-based measures. Conclusions: Specific microbial taxa may contribute to gut–brain signaling pathways implicated in MDD and systemic inflammation. Further longitudinal and mechanistic studies are required to clarify causal interactions within inflammation–microbiome networks in MDD. Full article
Show Figures

Figure 1

Back to TopTop